Publications by authors named "A Badkoobeh"

Purpose: The aim of this systematic review was to assess the outcome of non-vascularized iliac bone graft and vascularized iliac bone graft (VBG) in the reconstruction of mandibular defects.

Methods: An electronic search was conducted in PubMed, Google Scholar, Scopus, and Cochrane Library for relevant articles in English, French, and German languages published between 2010 and 2021 using the following keywords: ("mandibular reconstruction" [Mesh] OR "mandibular defect") AND (("deep circumflex iliac artery" OR "DCIA") OR ("non-vascularized iliac crest bone graft" OR "NVICBG") OR (("ilium" [Mesh] OR "iliac") AND ("free" OR "vascularized") AND "graft")). The National Institute of Health (NIH) quality assessment tool was used for risk of bias assessment.

View Article and Find Full Text PDF

The oral microbiome potentially wields significant influence in the development of cancer. Within the human oral cavity, an impressive diversity of more than 700 bacterial species resides, making it the second most varied microbiome in the body. This finely balanced oral microbiome ecosystem is vital for sustaining oral health.

View Article and Find Full Text PDF

Several studies suggest that oral pathogenic biofilms cause persistent oral infections. Among these is periodontitis, a prevalent condition brought on by plaque biofilm. It can even result in tooth loss.

View Article and Find Full Text PDF

Background: Several measures have been implemented to minimize the side effects of impacted third molar (M3) removal including the use of platelet-rich fibrin (PRF).

Purpose: This study compared the effects of three modifications of PRF (leukocyte-PRF [L-PRF], advanced-PRF [A-PRF], and advanced-PRF plus [A-PRF +]) on the side effects of impacted M3 removal.

Study Design, Setting, And Sample: This double-blinded randomized controlled trial was conducted at the Oral Surgery Department of Kashan University between September 2022 and May 2023 on patients undergoing mandibular impacted M3 removal.

View Article and Find Full Text PDF

The conventional approach for addressing bone defects and stubborn non-unions typically involves the use of autogenous bone grafts. Nevertheless, obtaining these grafts can be challenging, and the procedure can lead to significant morbidity. Three primary treatment strategies for managing bone defects and non-unions prove resistant to conventional treatments: synthetic bone graft substitutes (BGS), a combination of BGS with bioactive molecules, and the use of BGS in conjunction with stem cells.

View Article and Find Full Text PDF